Health
groups sue FDA for
Gilead hepatitis C
drug trial data
(Reuters) - The Food and
drug Administration was sued by two advocacy
groups seeking to force the faster disclosure of clinical
trial data that helped
Gilead Sciences Inc win approval for two blockbuster
hepatitis C *****.
